
Journal of Heterocyclic Chemistry p. 1737 - 1742 (1996)
Update date:2022-08-04
Topics:
Savelli, Francesco
Boido, Alessandro
Damonte, Gianluca
With a continuing interest on heteropolycyclic structures which may show biological activities, we synthesized new tricyclic derivatives in which the pyridopyrazine skeleton is fused with pyrazine 7 and 8, B, n = 1. However, the initial design of obtaining also the cyclohomologous structure B (n = 2) produced instead a pyranopyridopyrazine derivative 11. Thus during the attempt to prepare a pyridodiazepine intermediate, beside a very small amount of the desired product 10, the pyridopyrazine 9 was obtained. The latter compound reacted with chloroacetyl chloride/chloroketene to give 4-carbethoxy-10-(chloroacetyl)-5,10-dihydro-5-methyl-2H-pyrano[2,3-b]p yrido[2,3-e]pyrazin-2-one (11). In studying the behavior of this derivative, compounds 12-14 were obtained. Compounds 4b,c, 5a,b, 7, 8, 9 and 14 have been submitted to preliminary pharmacological screening as CNS depressant agents.
View MoreShanghai Goyic Pharmaceutical&Chemical Co,. Ltd
Contact:+86-021-60275964
Address:No. 528 ruiqing road
Qingdao S. H. Huanyu Imp. & Exp. Co., Ltd.
Contact:86-532-88250866
Address:Room 615, World Trade Centre Building B, Hongkong Middle Roda 6#, Qingdao, Shandong, China
Linyi Shengxin Pharmaceutical R&D Co., Ltd
Contact:+86-18653953873
Address:West First of Yufeng Road, Yishui County
Contact:+86-13666670345
Address:Agricultural Development Zone, Haining, Jiaxing, Zhejiang
Contact:0086-29-88315623
Address:S711, Innovation Bldg No.25 Gaoxin 1st Rd, Xian P.R of China 710075
Doi:10.1002/cber.19971300211
(1997)Doi:10.1021/jo01082a005
(1960)Doi:10.1016/S0040-4020(98)00878-3
(1998)Doi:10.1021/ja037847q
(2004)Doi:10.1021/ic9610445
(1997)Doi:10.1021/ja01540a057
(1958)